These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38565698)

  • 1. Predicting cognitive function and dementia risk in patients with hypertension.
    Cerezo GH; Fernández RA; Enders JE; Vicario A;
    Hypertens Res; 2024 Jun; 47(6):1728-1734. PubMed ID: 38565698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Vascular Risk Score and CAIDE Dementia Risk Score Predict Cognitive Function in the Northern Manhattan Study.
    Rundek T; Gardener H; Dias Saporta AS; Loewenstein DA; Duara R; Wright CB; Dong C; Levin B; Elkind MSV; Sacco RL
    J Alzheimers Dis; 2020; 73(3):1221-1231. PubMed ID: 31884476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clock drawing test as a cognitive screening tool for assessment of hypertension-mediated brain damage.
    Cerezo GH; Conti P; De Cechio AE; Del Sueldo M; Vicario A;
    Hipertens Riesgo Vasc; 2021; 38(1):13-20. PubMed ID: 32948501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive disorder in hypertensive patients. Heart-Brain Study.
    Vicario A; Cerezo GH; Del Sueldo M; Zilberman J; Pawluk SM; Lódolo N; De Cerchio AE; Ruffa RM; Plunkett R; Giuliano ME; Forcada P; Hauad S; Flores R;
    Hipertens Riesgo Vasc; 2018; 35(4):169-176. PubMed ID: 29456127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CAIDE Dementia Risk Score and the Honolulu-Asia Aging Study.
    Chosy EJ; Edland SD; Gross N; Meyer MJ; Liu CY; Launer LJ; White LR
    Dement Geriatr Cogn Disord; 2019; 48(3-4):164-171. PubMed ID: 31968337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAIDE Score, Alzheimer's Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study.
    Guo ZX; Liu F; Wang FY; Ou YN; Huang LY; Hu H; Wang ZB; Fu Y; Gao PY; Tan L; Yu JT
    J Alzheimers Dis; 2024; 99(4):1273-1283. PubMed ID: 38728186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Modified CAIDE Risk Score as a Screening Tool for Cognitive Impairment in Older Adults.
    Tolea MI; Heo J; Chrisphonte S; Galvin JE
    J Alzheimers Dis; 2021; 82(4):1755-1768. PubMed ID: 34219721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia.
    Mohanannair Geethadevi G; Quinn TJ; George J; Anstey KJ; Bell JS; Sarwar MR; Cross AJ
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014885. PubMed ID: 37265424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.
    Stephen R; Liu Y; Ngandu T; Rinne JO; Kemppainen N; Parkkola R; Laatikainen T; Paajanen T; Hänninen T; Strandberg T; Antikainen R; Tuomilehto J; Keinänen Kiukaanniemi S; Vanninen R; Helisalmi S; Levälahti E; Kivipelto M; Soininen H; Solomon A
    J Alzheimers Dis; 2017; 59(2):695-705. PubMed ID: 28671114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CAIDE dementia risk, cognition, CSF biomarkers, and vascular burden in healthy adults.
    Ecay-Torres M; Estanga A; Tainta M; Izagirre A; Garcia-Sebastian M; Villanua J; Clerigue M; Iriondo A; Urreta I; Arrospide A; Díaz-Mardomingo C; Kivipelto M; Martinez-Lage P
    Neurology; 2018 Jul; 91(3):e217-e226. PubMed ID: 29898969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midlife cardiovascular risk factors and late cognitive impairment.
    Virta JJ; Heikkilä K; Perola M; Koskenvuo M; Räihä I; Rinne JO; Kaprio J
    Eur J Epidemiol; 2013 May; 28(5):405-16. PubMed ID: 23532744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Dementia and Vascular Risk Scores With Cortical Thickness and Cognition in Low-risk Middle-aged Adults.
    Gourley D; Pasha EP; Kaur SS; Haley AP; Tanaka H
    Alzheimer Dis Assoc Disord; 2020; 34(4):313-317. PubMed ID: 32467426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midlife CAIDE dementia risk score and dementia-related brain changes up to 30 years later on magnetic resonance imaging.
    Vuorinen M; Spulber G; Damangir S; Niskanen E; Ngandu T; Soininen H; Kivipelto M; Solomon A
    J Alzheimers Dis; 2015; 44(1):93-101. PubMed ID: 25190628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia.
    Enache D; Solomon A; Cavallin L; Kåreholt I; Kramberger MG; Aarsland D; Kivipelto M; Eriksdotter M; Winblad B; Jelic V
    Neurobiol Aging; 2016 Jun; 42():124-31. PubMed ID: 27143429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores.
    Chhetri JK; de Souto Barreto P; Cantet C; Pothier K; Cesari M; Andrieu S; Coley N; Vellas B
    J Alzheimers Dis; 2018; 64(1):71-78. PubMed ID: 29865075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND).
    Stephan BCM; Minett T; Muniz-Terrera G; Harrison SL; Matthews FE; Brayne C
    Age Ageing; 2017 Sep; 46(5):755-760. PubMed ID: 28203692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third follow-up of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) cohort investigating determinants of cognitive, physical, and psychosocial wellbeing among the oldest old: the CAIDE85+ study protocol.
    Barbera M; Kulmala J; Lisko I; Pietilä E; Rosenberg A; Hallikainen I; Hallikainen M; Laatikainen T; Lehtisalo J; Neuvonen E; Rusanen M; Soininen H; Tuomilehto J; Ngandu T; Solomon A; Kivipelto M
    BMC Geriatr; 2020 Jul; 20(1):238. PubMed ID: 32650731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between 25-hydroxy vitamin D and cognitive status in older adults: the COGNIDAGE study].
    Manzo C; Castagna A; Palummeri E; Traini E; Cotroneo AM; Fabbo A; Natale M; Gareri P; Putignano S
    Recenti Prog Med; 2016 Feb; 107(2):75-83. PubMed ID: 26901583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cognitive profile in hypertensive patients. Usefulness of the Clock Drawing Test].
    Labos E; Vicario A; Cerezo G; Zabala K; Renato A
    Vertex; 2022 Mar; XXXIII(155):5-12. PubMed ID: 35438681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.